TOTAL ALLERGY CARE for HEALTH PROFESSIONALS
SIGN UP

Children’s ZYRTEC® 5 mg makes a significant impact on allergy symptoms1

In patients ages 2 to 6 years with seasonal allergic rhinitis (SAR), Children’s ZYRTEC® provides a powerful symptom response1

66% of children demonstrated ≥50% improvement from baseline SAR symptoms over 2 weeks.1

Randomized, placebo-controlled study of children aged 2 to 6 years with SAR during a 2-week period. Primary endpoint was the change in total symptom score complex from baseline.

*Significant vs placebo.

†ZYRTEC® 5 mg vs placebo ratio at ≥50% reduction is 1.84-fold.

Reference: 1. Data on file, Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division.

Learn more about Children's ZYRTEC®

Children's ZYRTEC® allergy products Children's ZYRTEC® allergy products

View Children's ZYRTEC® tolerability profile

Children play sword-fighting Children play sword-fighting

Caregiver Brochure

Help educate children and caregivers about allergies with an educational brochure and storybook.

Children's ZYRTEC® patient educational brochure and storybook Children's ZYRTEC® patient educational brochure and storybook